Fresenius SE & Co. KGaA (FRE.DE) stock analysis

In our weekly check, Fresenius SE & Co. KGaA is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 18 pass, warnings: 6, red flags: 1.

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA is a Healthcare company (Medical - Care Facilities) based in Germany, listed on XETRA as FRE.DE.

What our checks show for FRE.DE

Red flags

Warning signs

Strengths

Next earnings report: 2026-11-04

Similar companies

THC · FMS · EHC · DVA · UHS · ENSG

Questions

What grade does Fresenius SE & Co. KGaA (FRE.DE) have?

In our weekly check, Fresenius SE & Co. KGaA is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 18 pass, warnings: 6, red flags: 1. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of FRE.DE stock?

This week's biggest flags for Fresenius SE & Co. KGaA: Deep past fall, Gross margin falling, Weak revenue forecast. In total 7 of 25 checks show a warning or a red flag.

What does Fresenius SE & Co. KGaA do?

Fresenius SE & Co. KGaA is a Healthcare company (Medical - Care Facilities) based in Germany, listed on XETRA as FRE.DE.

When does Fresenius SE & Co. KGaA report earnings next?

The next earnings report is expected on 2026-11-04. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis